506. Adenovirus Vectors Transductionally Retargeted to Her2/Neu for Prostate Tumour Treatment

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)37947-3
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elsevier BV

Related search

545. Transductionally-Retargeted Infectivity Selective Oncolytic Adenovirus With Redesigned AB-Loop Targeting Cell Surface Mesothelin

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Adenovirus 5 Vector Genetically Re-Targeted by an Affibody Molecule With Specificity for Tumor Antigen HER2/neu

Cancer Gene Therapy
Cancer ResearchMolecular MedicineMolecular Biology
2007English

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery
Oncology
2013English

HER2 (ERBB2; Neu); Transferrin Receptor

Science-Business eXchange
2011English

Adenovirus Vectors for Gene Therapy

Uirusu. Journal of virology
Medicine
2003English

Taspase1 Cleaves MLL1 to Activate Cyclin E for HER2/neu Breast Tumorigenesis

Cell Research
Cell BiologyMolecular Biology
2014English

Her2/Neu Protein Expression in Colorectal Cancer

Journal of Evolution of Medical and Dental Sciences
2019English

Assessment of Genetic Shielding for Adenovirus Vectors

The Open Gene Therapy Journal
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy